TP53 and neoplasm: In triple-negative breast cancer (TNBC) cells, inhibition of HDAC8 increases the acetylation of YY1, decreasing its transcriptional activity and downregulating mutant p53 transcription, consequently repressing tumor cell proliferation [101].